Rusfertide was generally well-tolerated through 52 Weeks of treatment. The most common treatment-emergent adverse events (AE) in rusfertide-treated patients were injection site reactions (47.4%), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback